LCL161 18 is a pyrrolidine-thiazole-containing compound that triggers pyroptosis in pancreatic cancer, leukemia, and multiple myeloma cells by activating caspase-1 and GSDMD [106, 107]. This evidence concerns the gene GSDMD and familial pancreatic carcinoma.